体外受精在澳大利亚的发展
本文回顾了澳大利亚墨尔本体外受精(IVF)的发展历程:1970年Carl Wood在维多利亚女王医院成立研究组,1973年报道首例移植IVF胚胎后的生化妊娠,1980年参与确认英国研究组自然周期IVF妊娠,此后Monash研究组转向促排卵多卵泡发育并实现多胎妊娠,奠定可持续治疗方案的基础。文章还涉及胚胎冻融、卵母细胞捐赠与体外成熟、精子显微注射、胚胎活检与植入前遗传学诊断、卵巢组织冷冻保存及玻璃化等技术进展,并指出维多利亚州限制性胚胎研究法律影响了部分研究的及时临床应用。
要点
- 1970年Carl Wood在墨尔本维多利亚女王医院成立研究组,1973年报道首例移植IVF胚胎后的生化妊娠。
- 1980年该组参与确认英国研究组的自然周期IVF妊娠;Monash组转向促排卵多卵泡发育并于1980-1981年首次实现多胎妊娠。
- 维多利亚州限制性胚胎研究法律阻碍了胚胎活检与植入前遗传学诊断等研究的及时临床应用。
核心结论
- 澳大利亚墨尔本的研究组从1970年起推动IVF发展,建立了可持续的不孕症治疗方案,并在胚胎冻融、卵母细胞体外成熟、精子显微注射、胚胎活检及卵巢组织冷冻保存等方面取得进展。
- 维多利亚州限制性胚胎研究法律阻碍了部分研究(如胚胎活检用于植入前遗传学诊断)的及时临床应用。
研究设计与样本
- 本文为历史回顾性叙述,按时间顺序回顾1970年起澳大利亚墨尔本IVF相关研究组的工作。
主要发现
- 研究组于1973年报道首例移植IVF胚胎后的生化妊娠。
- 研究组于1980年参与确认英国研究组的自然周期IVF妊娠。
- Monash组在控制排卵周期中使用生育药物诱导多卵泡生长,于1980-1981年首次实现多胎妊娠。
- 成功的胚胎冻融方法首次实现妊娠,并被用于冷冻保存超促排卵后多余的胚胎。
- 为无排卵患者设计了胚胎捐赠方法,并首次报道在多囊卵巢综合征患者中使用卵母细胞体外成熟技术(IVM)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In vitro fertilization (IVF) began in Melbourne in 1970 when Carl Wood founded a research group at the Queen Victoria Hospital. The group reported the first biochemical pregnancy from a transferred IVF embryo in 1973. The group included the Royal Women's Hospital Melbourne, and they were the first to report confirmation of the British group's pregnancies with the use of IVF in natural cycles in 1980. The group then split, and the Monash group pursued fertility drug-induced multiple follicle growth in controlled ovulatory cycles and demonstrated for the first time that they could achieve multiple pregnancies in 1980-1981. This became the basis of a sustainable procedure for treating infertile patients. Successful embryo freezing and thawing methods resulted in pregnancies for the first time and were adopted to cryopreserve excess embryos produced after superovulation. Embryo donation methods were devised for anovulatory patients and were the first reported use of oocyte in vitro maturation techniques (IVM) for polycystic ovarian syndrome patients. Sperm microinjection techniques were pioneered for enabling fertilization for severely infertile men, and micromanipulative techniques were published for embryo biopsy for potential use in preimplantation genetic diagnosis (PGD) for patients with inheritable genetic diseases. The latter research programs were hampered by creation of restrictive embryo research laws in the State of Victoria, handicapping their timely clinical applications. Work on cryopreservation of ovarian tissue for cancer patients enabled clinical application of this for patients at risk of loss of fertility. Vitrification was developed as an alternative to freezing for oocytes and embryos, and this has now replaced the original slow cooling methods. Blastocyst culture systems were devised and optimized to improve IVF success and PGD.
引用
- Trounson A. Development of in vitro fertilization in Australia. Fertil Steril. 2018. PMID: 29980258. doi:10.1016/j.fertnstert.2018.02.126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。